Inventor · disambiguated record
Chad Oh
Also filed as: OH CHAD · OH CHAD K
10 granted patents·4 pending applications·11 citations·filing 2001–2025
82Inventor score
Files withGLENMARK SPECIALTY SA9GLENMARK PHARMACEUTICALS LTD2AEON BIOPHARMA INC1REVANCE THERAPEUTICS INC1TANOX INC1
Top patents by PatentIndex Score
14 records- 0191US12303635B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2023·Granted May 20, 2025·1 cites·10 claims
- 0282US10016443B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Jul 10, 2018·2 cites·24 claims
- 0381US2024156840A1Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2023·Application pending·0 cites
- 0478US12064442B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 0571US10548907B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Feb 4, 2020·1 cites·32 claims
- 0670US11400101B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2020·Granted Aug 2, 2022·0 cites·26 claims
- 0769US6767540B2Use of antagonists of plasminogen activator inhibitor-1 (PAI-1) for the treatment of asthma and chronic obstructive pulmonary diseaseTANOX INC·Filed 2001·Granted Jul 27, 2004·6 cites·12 claims
- 0867US11679210B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2018·Granted Jun 20, 2023·1 cites·16 claims
- 0964US2025242115A1Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2025·Application pending·0 cites
- 1058US10758550B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2018·Granted Sep 1, 2020·0 cites·32 claims
- 1157US2025064906A1Neurotoxin compositions for use in treating digestive disordersAEON BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 1255US10646500B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 12, 2020·0 cites·15 claims
- 1355US2024269246A1Methods for treating cervical dystoniaREVANCE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1450US10653661B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted May 19, 2020·0 cites·5 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →